HR Execs on the Move

ILC Dover

www.ilcdover.com

 
At SI Group, we create smart chemistry that solves global challenges and makes great things possible. We create smart chemistry that solves global challenges and makes great things possible. SI Group is a performance additives and intermediates business. We offer a broad array of products that feed into diverse applications including pharmaceuticals; plastics; oil and gas; and tires, among many others. We create solutions that provide formulators and manufacturers with the ability to increase efficacy, efficiency, productivity, and purity in countless industrial and consumer goods. Our company unites us. So do our values and the approach that we bring into ...
  • Number of Employees: 1K-5K
  • Annual Revenue: > $1 Billion
  • www.ilcdover.com
  • 100 Discovery Boulevard Suite 1001
    Newark, NE USA 19713
  • Phone: 302.335.3911

Executives

Name Title Contact Details
Gerardo Cisneros
Vice President Finance Profile
Kelly Lawry
Chief Human Resources Officer Profile
Scott Patterson
Vice President Pharma/Bio Technical Support Profile
Shelley Sharkey
Human Resources Director Profile
Rodrigo Tajonar
Global Human Resources Director Profile

Similar Companies

DSM Pharmaceutical Products

DSM is active worldwide in life science products, performance materials and industrial chemicals. The group has annual sales of close to EUR 5.6 billion and employs about 18,500 people at more than 200 sites across the world. DSM ranks among the global

Regulatory Compliance Associates Inc

Regulatory Compliance Associates Inc is a Kenosha, WI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

BN ImmunoTherapeutics

BN ImmunoTherapeutics is a Mountain View, CA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

AnkaBehavioralHealth

All of Ankas programs share the same mission: to eliminate the impact of behavioral health problems for all people.

ADARX

ADARx is a genetic medicine company focusing on the editing of Messenger RNA Targeting transcripts and oligonucleotide-based therapeutics.